Florence Depontieu

1.2k total citations
22 papers, 989 citations indexed

About

Florence Depontieu is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Florence Depontieu has authored 22 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Florence Depontieu's work include Inflammation biomarkers and pathways (10 papers), Pancreatitis Pathology and Treatment (8 papers) and Immunotherapy and Immune Responses (6 papers). Florence Depontieu is often cited by papers focused on Inflammation biomarkers and pathways (10 papers), Pancreatitis Pathology and Treatment (8 papers) and Immunotherapy and Immune Responses (6 papers). Florence Depontieu collaborates with scholars based in France, United States and Romania. Florence Depontieu's co-authors include Philippe Lassalle, Arnaud Scherpereel, Bogdan Grigoriu, André‐Bernard Tonnel, Maryse Delehedde, Estelle Adam, Sandrine Sarrazin, Hugues Lortat‐Jacob, David Béchard and Malcolm Lyon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

Florence Depontieu

20 papers receiving 973 citations

Peers

Florence Depontieu
Gary Nace United States
A. Zeevi United States
Zhengzi Yi United States
Florence Depontieu
Citations per year, relative to Florence Depontieu Florence Depontieu (= 1×) peers Rolf Loertscher

Countries citing papers authored by Florence Depontieu

Since Specialization
Citations

This map shows the geographic impact of Florence Depontieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Depontieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Depontieu more than expected).

Fields of papers citing papers by Florence Depontieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Depontieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Depontieu. The network helps show where Florence Depontieu may publish in the future.

Co-authorship network of co-authors of Florence Depontieu

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Depontieu. A scholar is included among the top collaborators of Florence Depontieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Depontieu. Florence Depontieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Gaëlle, Laura Cons, Florence Depontieu, et al.. (2025). Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapies. Frontiers in Immunology. 16. 1624724–1624724.
2.
Ménoret, Séverine, Florence Depontieu, Gaëlle Martin, Kader Thiam, & Ignacio Anegón. (2024). Efficient generation of human immune system rats using human CD34+ cells. Stem Cell Reports. 19(9). 1255–1263. 2 indexed citations
3.
Martin, Gaëlle, Florence Depontieu, Thomas Thisted, et al.. (2024). Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical model. Frontiers in Immunology. 15. 1357716–1357716. 4 indexed citations
4.
Depontieu, Florence, et al.. (2023). Abstract 4139: Functional human myeloid cells in BRGSF-HIS humanized mice enables myeloid-directed therapy assessment. Cancer Research. 83(7_Supplement). 4139–4139. 1 indexed citations
5.
Rogel, Anne, Stephen M. Thirdborough, Florence Depontieu, et al.. (2022). Fcγ receptor–mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies. JCI Insight. 7(19). 8 indexed citations
6.
Malaker, Stacy A., Michael J. Ferracane, Florence Depontieu, et al.. (2016). Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma. Journal of Proteome Research. 16(1). 228–237. 34 indexed citations
7.
Caires, Nathalie De Freitas, Florence Depontieu, Arnaud Scherpereel, et al.. (2014). The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction. Oncotarget. 6(5). 2725–2735. 11 indexed citations
8.
Chen, Shuming, Yili Li, Florence Depontieu, et al.. (2013). Structure-Based Design of Altered MHC Class II–Restricted Peptide Ligands with Heterogeneous Immunogenicity. The Journal of Immunology. 191(10). 5097–5106. 19 indexed citations
9.
Depontieu, Florence, Nathalie De Freitas Caires, Delphine Gourcerol, et al.. (2012). Development of monoclonal antibodies and ELISA specific for the mouse vascular endocan. Journal of Immunological Methods. 378(1-2). 88–94. 10 indexed citations
10.
Li, Yili, Florence Depontieu, John Sidney, et al.. (2010). Structural Basis for the Presentation of Tumor-Associated MHC Class II-Restricted Phosphopeptides to CD4+ T Cells. Journal of Molecular Biology. 399(4). 596–603. 31 indexed citations
11.
Depontieu, Florence, Jie Qian, Angela L. Zarling, et al.. (2009). Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proceedings of the National Academy of Sciences. 106(29). 12073–12078. 87 indexed citations
12.
Caires, Nathalie De Freitas, Sandrine Sarrazin, Florence Depontieu, et al.. (2009). In Vitro Pathways of Vascular Endocan Catabolism and Their Relevance in Sepsis.. A1156–A1156. 1 indexed citations
13.
Caires, Nathalie De Freitas, Sandrine Sarrazin, Florence Depontieu, et al.. (2009). Identification of cathepsin G in the generation of elastase-resistant fragment of vascular endocan: involvement in the regulation of LFA-1-dependent cascade. Critical Care. 13(Suppl 4). P16–P16. 5 indexed citations
14.
Depontieu, Florence, Arnaud Scherpereel, Estelle Adam, et al.. (2008). Loss of Endocan tumorigenic properties after alternative splicing of exon 2. BMC Cancer. 8(1). 14–14. 18 indexed citations
15.
Depontieu, Florence, Jie Qian, Angela L. Zarling, et al.. (2008). Tumor‐associated MHC II‐restricted phosphopeptides: New targets for immune recognition. The FASEB Journal. 22(S1). 1 indexed citations
16.
Scherpereel, Arnaud, Florence Depontieu, Bogdan Grigoriu, et al.. (2006). Endocan, a new endothelial marker in human sepsis*. Critical Care Medicine. 34(2). 532–537. 199 indexed citations
17.
Grigoriu, Bogdan, Florence Depontieu, Arnaud Scherpereel, et al.. (2006). Endocan Expression and Relationship with Survival in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 12(15). 4575–4582. 150 indexed citations
18.
Sarrazin, Sandrine, Estelle Adam, Malcolm Lyon, et al.. (2005). Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1765(1). 25–37. 279 indexed citations
19.
Lancel, Steve, Stéphanie Tissier, Serge Mordon, et al.. (2004). Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. Journal of the American College of Cardiology. 43(12). 2348–2358. 82 indexed citations
20.
Tissier, Stéphanie, Steve Lancel, Xavier Maréchal, et al.. (2004). CALPAIN INHIBITORS IMPROVE MYOCARDIAL DYSFUNCTION AND INFLAMMATION INDUCED BY ENDOTOXIN IN RATS. Shock. 21(4). 352–357. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026